ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention
Steven R. Bailey(Louisiana State University Health Sciences Center Shreveport), Evin Yucel, Heather L. Gornik(Asia Society), Sahil A. Parikh(NewYork–Presbyterian Hospital), Venkataramu N. Krishnamurthy, Piotr Sobieszczyk, Rita E. Shugart, Fadi Shamoun(Mayo Clinic in Arizona), L. Samüel Wann, Sanjay Misra(Mayo Clinic), Michael R. Jaff(Boston Scientific (United States)), Herbert D. Aronow, Timothy Dao, Bruce H. Gray, Amy B. Reed, Christopher J. White(Ochsner Medical Center), Jonathan L. Halperin, Reza Fazel, Alan T. Hirsch(University of Minnesota Medical Center), Joshua A. Beckman(Clinical Research Institute)
Cited by 171
Related Papers
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2011|2.2k
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
|Journal of the American College of Cardiology|2017|1.9k